The aesthetics landscape is expanding, both in volume and in definition. Industry boundaries are becoming more fluid as biological therapies enter the mainstream and aesthetic treatments increasingly intersect with wellness experiences. Today’s consumers are no longer interested in rejuvenation alone—regeneration is the new benchmark.
At the heart of this evolution are two converging forces: the rise of regenerative aesthetics and the expansion of aesthetic services into wellness-adjacent channels. From exosome-infused skincare to medspas appearing in gyms and hormone clinics, the patient journey is shifting, and with it, the landscape of opportunity.
Inside-Out Innovation: What Exosomes and Wellness Models Signal About the Future of Aesthetic Care
For commercial leaders, marketers, and product teams, the market is evolving faster than the traditional playbook can keep up. Guidepoint Qsight’s real-time insights give aesthetic manufacturers and investors the clarity they need to navigate this change and act ahead of the curve.
Regenerative Aesthetics: From Trend to Treatment Philosophy
Regenerative aesthetics is a growing product category that signals a deeper philosophical shift in the industry. Rather than layering over signs of aging, regenerative treatments stimulate the body’s own repair processes: restoring collagen, boosting angiogenesis, and enhancing long-term skin function and structure.
We’re already seeing that vision reflected in patient behavior and practice adoption. Here’s what the Qsight Sales Measurement data is telling us:
- Exosome-related skin rejuvenation procedures grew 20% per facility in the 12 months ending April 2025, compared to 3.6% growth in the broader non-energy-based-device (EBD) skin rejuvenation segment.
- A year earlier, exosome-related treatments surged 53% while the broader category declined nearly 5%.
- Microneedling procedures paired with exosomes increased nearly 10% this past year, building on a 160% rise the year prior.
In contrast, PRP therapy has declined 7% year-over-year for two straight years. The gap between emerging and legacy regenerative categories is widening, and it’s happening quickly.
For manufacturers, this shift signals where patient trust and clinical adoption are building momentum—critical inputs for investment decisions and go-to-market timing.
Premium Skincare Enters the Regenerative Era
The exosome effect extends beyond procedures and into retail skincare. Qsight Sales Measurement data shows the broader Professional Grade Skincare (PGS) market remained flat in the last year—down 0.1% YoY—yet exosome-based products tell a different story.
- (plated)™, an exosome-powered brand, saw 26.2% growth in per-practice sales in the past year, on top of 47.2% growth in the year prior.
- In just 24 months, its market share jumped from 0.7% to 2.4%.
This signals not only patient appetite for regenerative ingredients but also provider confidence in incorporating them into their service menu. As more brands experiment with PDRN and other regenerative ingredients, Qsight Sales Measurement helps differentiate what’s truly gaining traction from what’s merely generating buzz.
The Wellness-Aesthetics Crossover Is Already Here
Regenerative aesthetics is just one half of the market transformation. The other is where—and how—these treatments are being delivered.
Qsight Prospector data reveals:
- More than 4,100 aesthetic practices and medspas now offer some form of exosomal therapy
- 2,500 aesthetic practice and medspa websites reference the word “regenerative”
- Over 11,900 aesthetic websites reference “wellness”
- 2,700+ practices include “wellness” in their name
- 107 locations include “regenerative” in their brand identity
This confirms what many marketers and sales leaders have suspected: aesthetic services are becoming part of the broader wellness economy. From hormone clinics to boutique fitness studios to women’s health centers, a new class of crossover practice is emerging. And it’s one often untapped by traditional sales teams.
Qsight’s Prospector platform helps sales teams identify and prioritize these accounts, filtering by treatment offerings, revenue size, and geographic relevance. For product launches or channel partnerships, this data can reveal non-obvious paths to high-quality growth.
Strategic Implications for Product, Sales, and Investment Teams
What does all this mean for business leaders on the strategy or product side? The convergence of regenerative treatment trends and wellness-oriented delivery models raises critical questions for commercial and product teams:
- Is your pipeline aligned with the regenerative category’s growth curve, or are you waiting for consensus that may arrive too late?
- Are you allocating R&D investment toward therapies with long-term market pull?
- Are your reps equipped to identify high-value leads in wellness-affiliated channels, or are they still prioritizing traditional medspas only?
- Are you adapting messaging to speak to patients seeking long-term restoration, not just short-term enhancement?
Qsight provides the data to answer these questions. Sales Measurement surfaces purchasing behavior that validates (or challenges) your strategy. Prospector identifies exactly where those behaviors are happening—so you can act on the signal, not the noise.
Make the First Move on What’s Next
Regenerative aesthetics and wellness crossovers aren’t speculative ideas—they’re measurable, actionable trends already shaping how and where patients spend.
Qsight gives your team the tools to move with certainty, aligning product, sales, and marketing strategy with where the market is actually going.
Request a Demo to See the Data in Action
Discover how Qsight’s Sales Measurement and Prospector tools can support your next move. Request a demo to explore the trends shaping aesthetics and uncover actionable insights for your team.